Our conference will be bilingual, i.e. that there will be both French and English presentations. A simultaneous translation service will be offered throughout the conference. Thus, you will be able to listen to the conference in the original language or in the translated language.
The program includes two pre-recorded presentations that can be viewed online at any time during the week of the Acfas Congress:
1. Medications and Pregnancy - French Experience (Pre-recorded presentation)
By Christine Damase-Michel, Paul Sabatier University Toulouse III
2. The importance of treatment for high-risk conditions in pregnancy (Pre-recorded presentation)
By Christina Chambers, University of California San Diego
These pre-recorded presentations will also be available for viewing after the conference via CAMCCO-L.
7:30 - 8:15 EDT: Welcome and Breakfast
8:15 - 8:30 EDT: Welcoming Words
By Anick Bérard, University of Montreal, CAMCCO and CAMCCO-L Principal Investigator
Medications, Pregnancy and Real-World Data (8:30 - 10:45 EDT)
8:30 - 9:00 EDT: Medications and Pregnancy - American Experience
By Leyla Sahin, U.S. Food and Drugs Administration (FDA)
9:00 - 9:30 EDT: Medications and Pediatrics - French Experience
By Behrouz Kassai Koupai, Université Claude Bernard Lyon 1
9:30 - 10:15 EDT: Medications and Pregnancy - Belgian Experience
By Michael Ceulemans, KU Leuven
10:15 - 10:45 EDT: Medications and Pregnancy - Canadian Experience - Canadian Mother-Child Cohort (CAMCCO)
By Anick Bérard, Université de Montréal, Principal Investigator CAMCCO and CAMCCO-L
10:45 - 11:15 EDT: Health Break
Student Oral Presentations (11:15 - 12:30 EDT)
11:15 - 11:30 EDT: Jessica Gorgui et al. Trends in the use of medically assisted procreation and perinatal outcomes in Quebec between 2005 and 2015 - the impact of the universal access program: an analysis of interrupted time series. UdeM, CHU Sainte-Justine and McGill University.
11:30 - 11:45 EDT: Alekhya Lavu et al. Antiseizure medication use in pregnancy and adverse neonatal birth outcomes: a population-based cohort study. University of Manitoba and University of Alberta.
11:45 - 12:00 EDT: Anaëlle Monfort et al. The passage of drugs into breast milk: new data for poorly tested drugs. UdeM.
12:00 - 12:15 EDT: Animesh Kumar Paul et al. Estimating the adverse outcomes of prescribed medications administered to pregnant women. University of Alberta.
12:15 - 12:30 EDT: Narimene Ait Belkacem et al. Maternal mental health during the COVID-19 pandemic and its impact on children's cognitive development. UdeM and CHU Sainte-Justine.
12:30 - 14:00 EDT: Lunch
Poster presentations (13:00 - 14:00 EDT) *On-site only*.
1. Rong Luo et al. Gestational diabetes mellitus in Ontario: temporal trends, risk factors, and birth outcomes. University of Ottawa, Ottawa Hospital Research Institute, Children's Hospital of Eastern Ontario and The Ottawa Hospital.
2. Leah K. Flatman et al. Tumour Necrosis Factor Inhibitors Use and Discontinuation Among Pregnant Women with Chronic Inflammatory Diseases. McGill University, RI-MUHC, MUHC, UdeM, CHU Sainte-Justine and Claude Bernard Lyon 1 University.
3. Lauren Tailor et al. Validation study of an aspirin prophylaxis variable for preeclampsia prevention. University of Toronto and Hospital for Sick Children.
4. Ugochinyere Vivian Ukah et al. Severe maternal morbidity and risk of serious neonatal complications. McGill University, HealthPartners Institute, INSPQ, CHUM and UdeM.
5. Menelaos Konstantinidis et al. Methods for meta-analysis in Updated and Living Systematic Reviews: An empirical study. University of Toronto and St. Michael's Hospital of Unity Health Toronto.
6. Laila Aboulatta et al. Impact of COVID-19 on prenatal care and adverse pregnancy outcomes in Manitoba, Canada. University of Manitoba, Karolinska Institutet, University of Washington, Manitoba Centre for Health Policy, Australian National University, Children's Hospital Research Institute of Manitoba.
7. Judith Zarek et al. Pregnancy Induced Pharmacokinetic Changes of Antiphospholipid Syndrome Medications: A Systematic Review. University of Toronto, TRIO Fertility and Hospital for Sick Children.
8. Maya Laham et al. Impact of levothyroxine use during pregnancy in hypothyroidism, on perinatal outcomes and child neurocognitive development. UdeM, CHU Sainte-Justine and Claude Bernard Lyon 1 University.
9. Sabine Mainbourg et al. In-utero exposure to azathioprine and neurodevelopmental disorders in children. UdeM and CHU Sainte-Justine.
10. Payam Peymani et al. Patterns of antiseizure medications prescriptions among pregnant people with epilepsy: a utilization study in three Canadian provinces. University of Manitoba, University of Saskatchewan, Saskatchewan Health Quality Council, University of Alberta, CHU Sainte-Justine, UdeM, University of Washington, Karolinska Institutet, Manitoba Centre for Health Policy and Children's Hospital Research Institute of Manitoba.
11. Linda Ok et al. The Effect of Depression and SSRI Treatment During Pregnancy on protein expression in the human placenta: a quantitative proteomics Analysis. INRS, UQAM, University of British Columbia and BC Children's Hospital Research Institute.
12. Nahiyan Saiyara Khan et al. COVID-19 during pregnancy: prevalence, predictors and impact on the newborn. UdeM, CHU Sainte-Justine and Claude Bernard Lyon 1 University.
13. Shenthuraan Tharmarajah et al. Changes in Diclectin Utilization Trends in Ontario Following Media Attention: A Time Series Analysis. University of Toronto and Women's College Hospital.
14. Catherine Stratton et al. Comparative Safety and Efficacy of Non-Opioid Prescriptions and Non-Prescription Treatments for Preexisting Chronic Pain in the Perinatal Period: A Scoping Review Protocol. University of Toronto and St. Michael's Hospital of Unity Health Toronto.
15. Jessica Gorgui et al. The impact of prenatal maternal mental health during the COVID-19 pandemic on birth outcomes: A study within the CONCEPTION cohort. CHU Sainte-Justine, UdeM, Claude Bernard Lyon 1 University and McGill University.
14:00 - 15:00 EDT: Workshop - Common protocols and common data model in perinatal pharmacoepidemiology using real-world data - Big Data. SAS scripts/programs - Mother-child analyses; Longitudinal period of exposure in medication and pregnancy studies; Defect definitions and codes - SAS programs.
By Odile Sheehy, CHU Sainte-Justine, CAMCCO-Research, Chief Biostatistician
15:00 - 15:45 EDT: Transdisciplinary Training Program on Medications and Pregnancy - Virtual CAMCCO-L Curriculum and Program Assessment
By Claudie Turcotte, CHU Sainte-Justine, CAMCCO-L Platform Coordinator
15:45 - 16:15 EDT: Break
16:15 - 17:15 EDT: mRNA vaccines in pregnant women: efficacy, risks and importance of innovation
By Deshayne B Fell, University of Ottawa
17:15 - 17:30 EDT: Last words
By Anick Bérard, University of Montreal, CAMCCO and CAMCCO-L Principal Investigator
17:30 - 18:30 EDT: Cocktail
Register now for the ACFAS Congress to attend our Conference on Medications and Pregnancy.
An ACFAS user account is required to register for the Congress.
.png)
.png)
.png)
%20(1).png)
666.png)
%20(Stroke).svg){kind=small}
